{
  "meta": {
    "data_length": 1,
    "message": "Therapy id tx:ncit:C151967 retrieved successfully",
    "request_url": "http://api.moalmanac.org/therapies?therapy_id=tx%3Ancit%3AC151967",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.001612,
    "timestamp_received": "2026-09-25T00:13:38.948038+00:00Z",
    "timestamp_returned": "2026-09-25T00:13:38.949650+00:00Z",
    "trace_id": "f2feb0aa-f67e-486c-9a5e-a87f7b66906d"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-08-02"
  },
  "data": [
    {
      "id": "tx:ncit:C151967",
      "conceptType": "Therapy",
      "name": "Datopotamab deruxtecan",
      "mappings": [
        {
          "relation": "relatedMatch",
          "coding": {
            "id": "coding:rxcui:2703033",
            "code": "2703033",
            "name": "datopotamab deruxtecan",
            "system": "RxNorm",
            "systemVersion": "02-Mar-2026",
            "iris": [
              "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=2703033"
            ]
          }
        },
        {
          "relation": "relatedMatch",
          "coding": {
            "id": "coding:omop:1465264",
            "code": "1465264",
            "name": "datopotamab deruxtecan",
            "system": "OMOP",
            "systemVersion": "v20260227",
            "iris": [
              "https://athena.ohdsi.org/search-terms/terms/1465264"
            ]
          }
        }
      ],
      "extensions": [
        {
          "name": "therapy_strategy",
          "value": [
            "Topoisomerase inhibition",
            "Trop-2 directed antibody"
          ],
          "description": "Associated therapeutic strategy or mechanism of action of the therapy."
        },
        {
          "name": "therapy_type",
          "value": "Targeted therapy",
          "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
        }
      ],
      "primaryCoding": {
        "id": "coding:ncit:C151967",
        "code": "C151967",
        "name": "Datopotamab Deruxtecan",
        "system": "https://evsexplore.semantics.cancer.gov",
        "systemVersion": "25.01d",
        "iris": [
          "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C151967"
        ]
      }
    }
  ]
}